0001209191-18-020205.txt : 20180316
0001209191-18-020205.hdr.sgml : 20180316
20180316164022
ACCESSION NUMBER: 0001209191-18-020205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novack David F
CENTRAL INDEX KEY: 0001573072
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 18696149
MAIL ADDRESS:
STREET 1: 39 YORKSHIRE DR
CITY: OAKLAND
STATE: CA
ZIP: 94618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-15
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001573072
Novack David F
C/O DYNAVAX TECHNOLOGIES
2929 SEVENTH STREET, SUITE 100
BERKELEY
CA
94710
0
1
0
0
Senior Vice President
Common Stock
2018-03-15
4
S
0
16109
16.3017
D
0
D
This transaction was executed in multiple trades at prices ranging from $16.300 to $16.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ David Novack
2018-03-16